Download PDF
Fortschr Neurol Psychiatr 2003; 71: 3-9
DOI: 10.1055/s-2003-40499
Originalarbeit
© Georg Thieme Verlag Stuttgart · New York

Glutamat - Ein Transmitter im Spannungsfeld zwischen Toxin und Trophin

Glutamate - A Transmitter in the Tensionfield Between Toxin and TrophineKonstanze  D.  Römer1 , S.  Bleich1 , J.  Kornhuber1
  • 1Klinik mit Poliklinik für Psychiatrie und Psychotherapie, Friedrich-Alexander-Universität zu Erlangen-Nürnberg
Further Information

Publication History

Publication Date:
08 July 2003 (online)

    Permissions and Reprints

Zusammenfassung

Glutamat ist der wichtigste exzitatorische Neurotransmitter im Zentralnervensystem. Seine Wirkungsweise ist ebenso vielfältig wie es die molekularen Strukturen der durch Glutamat aktivierbaren Rezeptoren sind. Das glutamaterge System nimmt modulierenden Einfluss auf nahezu sämtliche Neurotransmittersysteme. Zudem spielt Glutamat in wichtigen zentralnervösen Prozessen wie der hippokampalen Langzeitpotenzierung, einem zellulären Modell für Lernen und Gedächtnis, und der zentralen Sensibilisierung für Schmerzreize im Hinterhorn des Rückenmarks eine zentrale Rolle, die insbesondere über den NMDA-Rezeptor vermittelt wird. Doch die Wirkung von Glutamat geht weit über seine Wirkung als exzitatorischer Neurotransmitter hinaus. So entfaltet Glutamat zumindest in bestimmten Entwicklungsphasen des Zentralnervensystems auch eine neurotrophische Wirkung. Die über den NMDA-Rezeptor vermittelte Exzitotoxizität von Glutamat ist als gemeinsame Endstrecke des akuten wie auch des chronischen Nervenzelluntergangs von entscheidender Bedeutung im Hinblick auf zahlreiche akute neurologische, neurodegenerative und neurometabolische Erkrankungen. Von einer Modulation des glutamatergen Systems z. B. durch Glutamatantagonisten erhofft man sich daher neuartige Therapien dieser pathogenetisch unterschiedlichen Erkrankungen.

Abstract

Glutamate is the most important excitatory transmitter in the central nervous system. A tremendous complexity in the actions of this excitatory transmitter was found and an equally great complexity in the molecular structures of the receptors activated by glutamate. The glutamate receptor system influences nearly all other neurotransmitter systems. Glutamate also plays a central role in important processes of the central nervous system like the long-term potentiation in the hippocampus and the central sensitization for pain stimuli in the spinal cord, which is predominantly mediated by NMDA-receptors. But there are actions of glutamate beyond its function as an excitatory transmitter. Glutamate also has a trophic influence on neurons - depending upon the developmental stage. The excitotoxicity of glutamate mediated by NMDA-receptors is the common ultimate mechanism of acute and chronical nerve cell death and plays an important role in many acute neurologic diseases. The modulation of the glutamate system for example by antagonist of the glutamate-receptors might be a possible way in therapy of many different diseases of the central nervous system.

Literatur

  • 1 Michaelis E K. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging.  Progress in Neurobiology. 1998;  45 369-415
    PubMedGoogle Scholar
  • 2 Bleich S, Degner D, Bandelow B, Ahsen N von, Rüther E, Kornhuber J. Plasma Homocysteine is a predictor of alcohol withdrawal seizures.  NeuroReport. 2000;  11 2749-2752
    Google Scholar
  • 3 Bleich S, Spilker K, Kurth C, Degner D, Quintela-Schneider M, Javaheripour K, Rüther E, Kornhuber J, Wiltfang J. Oxidative stress and an altered methionine metabolism in alcoholism.  Neurosci Lett. 2000;  293 171-174
    CrossrefPubMedGoogle Scholar
  • 4 Bleich S, Degner D, Kornhuber J. Repeated ethanol withdrawal delays development of focal seizures in hippocampal kindling.  Alcohol Clin Exp Res. 2000;  24 244-245
    PubMedGoogle Scholar
  • 5 Bleich S, Degner D, Wiltfang J, Maler J M, Niedmann P, Cohrs S, Mangholz A, Protzig J, Spring R, Rüther E, Kornhuber J. Elevated homocysteine levels in alcohol withdrawal.  Alcohol Alcohol. 2000;  35 351-354
    Google Scholar
  • 6 Heresco-Levy U, Javitt D C. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndroms.  European Neuropsychopharmacology. 1998;  8 141-152
    CrossrefPubMedGoogle Scholar
  • 7 Parsons C G, Danysz W, Quack G. Glutamate in CNS disorders as a target for drug development: an update.  Drug News Perspect. 1998;  11 523-569
    CrossrefPubMedGoogle Scholar
  • 8 Spanagel R, Kornhuber J. Glutamatrezeptorantagonisten und Alkoholabhängigkeit.  Nervenarzt. 1999;  70 479-481
    CrossrefPubMedGoogle Scholar
  • 9 Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system.  Progress in Neurobiology. 1998;  54 581-618
    CrossrefPubMedGoogle Scholar
  • 10 Danbolt N C. Glutamate uptake.  Progress in Neurobiology. 2001;  65 1-105
    CrossrefPubMedGoogle Scholar
  • 11 Fadda F, Rossetti Z L. Chronic ethanol consumption: from neuroadaptation to neurodegeneration.  Progress in Neurobiology. 1998;  56 385-431
    CrossrefPubMedGoogle Scholar
  • 12 Meldrum B S. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology.  J Nutr Suppl. 2000;  130 1007-1015
    PubMedGoogle Scholar
  • 13 Fonnum F. Glutamate: A neurotransmitter in mammalian brain.  J Neurochemistry. 1984;  42 1-11
    PubMedGoogle Scholar
  • 14 Kornhuber J, Bleich S. Memantin. In: Riederer P, Laux G, Pöldinger W (Hrsg). Neuro-Psychopharmaka. Wien: Springer 1999: 687-704
    Google Scholar
  • 15 Cotman C W, Kahle J S, Miller S E, Ulas J, Bridges R J. Excitatory Amino Acid Neurotransmission. In: Bloom FE, Kupfer DJ (Hrsg). Psychopharmacology: The fourth Generation of Progress New York: Raven Press 1995: 75-85
    Google Scholar
  • 16 Mayer M L, Westbrook G L. The physiology of excitatory amino acids in the vertebrate nervous system.  Prog Neurobiol. 1987;  28 198-276
    PubMedGoogle Scholar
  • 17 Collingridge G L, Bliss T V. NMDA receptors - their role in long-term potentiation.  TINS. 1987;  10 288-293
    PubMedGoogle Scholar
  • 18 Collingridge G L, Kehl S J, McLennan H. The antagonism of amino acid-induced excitations of rat hippocampal CA1 neurons in vitro.  J Physiol. 1983;  334 19-31
    PubMedGoogle Scholar
  • 19 Errington M L, Lynch M A, Bliss T V. Long-term potentation in the dentate gyrus: induction and increased glutamate release are blocked by D-aminophosphonovalerate.  Neuroscience. 1987;  20 279-284
    CrossrefPubMedGoogle Scholar
  • 20 Bliss T V, Errington M L, Laroche S, Lynch M A. Increase in K+-stimulated, Ca2+-dependent release of [3H] glutamate from rat dentate gyrus three days after induction of long-term potentation.  Neurosci Lett. 1987;  83 107-112
    CrossrefPubMedGoogle Scholar
  • 21 Woolf C J, Salter M W. Neuronal plasticity and the generation of inflammatory pain.  Proc Natl Acad Sci. 2000;  288 1765-1769
    CrossrefPubMedGoogle Scholar
  • 22 Sandkühler J. Learning and memory in pain pathways.  Pain. 2000;  88 113-118
    CrossrefPubMedGoogle Scholar
  • 23 Basbaum A I, Fields H L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.  Neuroscience. 1984;  7 309-338
    CrossrefPubMedGoogle Scholar
  • 24 Castro-Lopes J M, Tavares I, Coimbra A. GABA decreases in the spinal cord dorsal horn after peripheral neurectomy.  Brain Res. 1993;  620 287-291
    CrossrefPubMedGoogle Scholar
  • 25 Liu H, Wang H, Sheng M, Jan L Y, Basbaum A I. Evidence for presynaptic N-methyl-D-aspartate receptors in the spinal cord dorsal horn.  Proc Natl Acad Sci USA. 1994;  91 8383-8387
    PubMedGoogle Scholar
  • 26 Neugebauer V, Kornhuber J, Lücke T, Schaible H G. The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurones.  NeuroReport. 1993;  4 1259-1262
    PubMedGoogle Scholar
  • 27 Lucas D R, Newhouse J P. The toxic effect of sodium L-glutamate on the inner layers of the retina.  AMA Arch Ophthalmol. 1957;  58 193-201
    PubMedGoogle Scholar
  • 28 Perl T M, Bédard L, Kosatsky T, Hockin J C, Todd E CD, Remis R S. An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid.  N Engl J Med. 1990;  322 1775-1780
    CrossrefPubMedGoogle Scholar
  • 29 Olney J W, Price M T, Salles K S, Labruyere J, Ryerson R, Mahan K, Friedrich G, Samson L. L-homocysteic acid: an endogenous excitotoxic ligand af the NMDA receptor.  Brain Res Bull. 1987;  19 597-602
    CrossrefPubMedGoogle Scholar
  • 30 Bouvier M, Szatkowski M, Amato A, Attwell D. The glial cell glutamate uptake carrier countertransports pH-changing anions.  Nature. 1992;  360 471-474
    CrossrefPubMedGoogle Scholar
  • 31 Clements J D, Lester R AJ, Tong G, Jahr C E, Westbrook G L. The time course of glutamate in the synaptic cleft.  Science. 1992;  258 1498-1501
    PubMedGoogle Scholar
  • 32 Arendash G W, Millard W J, Dunn A J, Meyer E W. Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat.  Science. 1987;  238 952-956
    PubMedGoogle Scholar
  • 33 Beal M F. Mechanisms of excitotoxicity in neurologic diseases.  FASEB J. 1992;  6 3338-3344
    PubMedGoogle Scholar
  • 34 Chapman A G. Glutamate and epilepsy.  J Nutr Suppl. 2000;  130 1043-1045
    PubMedGoogle Scholar
  • 35 DeBoni U, McLachlan D RC. Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons, by glutamate and aspartate.  J Neurol Sci. 1985;  68 105-118
    CrossrefPubMedGoogle Scholar
  • 36 Koh J Y, Yang L L, Cotman C W. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage.  Brain Res. 1990;  533 315-320
    CrossrefPubMedGoogle Scholar
  • 37 Mattson M P, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel R E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.  J Neurosci. 1992;  12 376-389
    PubMedGoogle Scholar
  • 38 Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease.  TiPS. 1990;  11 379-387
    CrossrefPubMedGoogle Scholar
  • 39 Lipton S A, Rosenberg P A. Mechanisms of disease: Excitatory amino acids as a final common pathway for neurologic disorders.  N Eng J Med. 1994;  330 613-622
    CrossrefPubMedGoogle Scholar
  • 40 Kornhuber J, Bormann J, Retz W, Hübers M, Riederer P. Memantine displaces [³H]MK-801 at therapeutic concentrations in postmortem human frontal cortex.  European Journal of Pharmacology. 1989;  166 589-590
    CrossrefPubMedGoogle Scholar
  • 41 Kornhuber J, Bormann J, Hübers M, Rusche K, Riederer P. Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.  European Journal of Pharmacology. 1991;  206 297-300
    CrossrefPubMedGoogle Scholar
  • 42 Kornhuber J, Bleich S, Wiltfang J, Maler M, Parsons C G. Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation af voltage independent potassium channels.  J Neural Transm. 1999;  106 857-867
    CrossrefPubMedGoogle Scholar
  • 43 Ripley T L, Little H J. Effects of chronic ethanol withdrawal hyperexcitability of chronic treatment with a competitive N-methyl-D-aspartate receptor antagonist.  J Pharmacol Exp Ther. 1995;  272 112-118
    PubMedGoogle Scholar
  • 44 Allen H L, Iversen L L. Phencyclidine, dizocilpine, and cerebrocortical neurons.  Science. 1990;  247 221
    PubMedGoogle Scholar
  • 45 Olney J W, Labruyere J, Price M T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs.  Science. 1989;  244 1360-1362
    PubMedGoogle Scholar
  • 46 Minabe Y, Tamura A. Memantine induces heat shock protein HSP70 in the posterior cingulate cortex, retrosplenial cortex and dentate gyrus of rat brain.  Brain Res. 1996;  740 1-5
    CrossrefPubMedGoogle Scholar
  • 47 Sharp F R, Jasper P, Hall J, Noble L, Sagar S M. MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex.  Ann Neurol. 1991;  30 801-809
    CrossrefPubMedGoogle Scholar
  • 48 Tomitaka S, Hashimoto K, Narita N, Sakamoto A, Rakic P, Sidman R L. Organization of the cerebellar cortex secondary to deficit of granule cells in weaver mutant mice.  J Comp Neurol. 1973;  152 133-162
    PubMedGoogle Scholar
  • 49 Danysz W, Parsons C G, Kornhuber J, Schmidt W J, Quack G. Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies.  Neurosci Biobehav Rev. 1997;  21 455-468
    CrossrefPubMedGoogle Scholar
  • 50 Kornhuber J, Weller M, Schoppmeyer K, Riederer P. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.  J Neural Transm Suppl. 1994;  43 91-104
    PubMedGoogle Scholar
  • 51 Kornhuber J, Jellinger K, Wiltfang J, Leblhuber F, Riederer P. The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissue.  Acta Neuropathol (Berl). 1999;  98 85-90
    CrossrefPubMedGoogle Scholar
  • 52 Kornhuber J, Weller M. Psychotogenicity and NMDA receptor antagonism: implications for neuroprotective pharmacotherapy.  Biol Psychiatry. 1997;  41 135-144
    PubMedGoogle Scholar
  • 53 Misztal M, Frankiewicz T, Parsons C G, Danysz W. Learning deficits induced by chronic intraventriculas infusion of quinolinic acid - protection by MK-801 an memantine.  Eur J Pharmacol. 1996;  296 1-8
    CrossrefPubMedGoogle Scholar
  • 54 Wenk G L, Danysz W, Roice D D. The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis magnocellularis.  Eur J Pharmacol. 1995;  293 267-270
    PubMedGoogle Scholar
  • 55 Kornhuber J, Quack G. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man.  Neuroscience letters. 1995;  195 137-139
    CrossrefPubMedGoogle Scholar
  • 56 Kroemer R T, Koutsilieri E, Hecht P, Liedl K R, Riederer P, Kornhuber J. Quantitative Analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site.  J Med Chem. 1998;  41 393-400
    CrossrefPubMedGoogle Scholar
  • 57 Balázs R, Hack N, Jorgensen O S. Stimulation of the N-methyl-D-aspartate receptor has a trophic effect on differentiating cerebellar granule cells.  Neuroscience Letters. 1988;  87 80-86
    CrossrefPubMedGoogle Scholar
  • 58 Balázs R, Jorgensen O S, Hack N. N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture.  Neuroscience. 1988;  27 437-451
    CrossrefPubMedGoogle Scholar
  • 59 Balázs R, Hack N, Jorgensen O S, Cotman C W. N-Methyl-D-aspartate promotes the survival of cerebellar granule cells: pharmacological characterization.  Neuroscience Letters. 1989;  110 241-246
    PubMedGoogle Scholar
  • 60 Balázs R, Resink A, Hack N, Valk J BF van der, Kumar K N, Michaelis E. Neuroscience Letters. 1992;  137 109-113
    CrossrefPubMed
  • 61 Gallo V, Kingbury A, Balázs R, Jorgensen O S. The role of depolarization in the survival and differentation of cerebellar granule cells in culture.  J Neurosci. 1987;  7 2203-2213
    PubMedGoogle Scholar
  • 62 Rakic P, Sidman R L. Organization of the cerebellar cortex secondary to deficit of ganule cells in weaver mutant mice.  J Comp Neurol. 1973;  133-163
    PubMedGoogle Scholar
  • 63 Burgoyne R D, Cambray-Deakin M A. The cellular neurobiology of neuronal development: the cerebellar granule cell.  Brain Res Rev. 1988;  13 77-101
    CrossrefPubMedGoogle Scholar
  • 64 Rauschecker J P, Hahn S. Ketamine-xylazine anaesthesia blocks consolidation of ocular dominance changes in kitten visual cortex.  Nature (London). 1987;  326 183-185
    CrossrefPubMedGoogle Scholar

Dr. med. Konstanze D. Römer

Friedrich-Alexander-Universität zu Erlangen-Nürnberg · Klinik mit Poliklinik für Psychiatrie und Psychotherapie

Schwabachanlage 6 - 10

91054 Erlangen

Email: Konstanze.Roemer@psych.imed.uni-erlangen.de

      >